FDA label
What is Miebo used for?
Miebo contains perfluorohexyloctane. The FDA-approved uses below are quoted from the Indications and Usage section of its DailyMed label.
Source: DailyMed SPL label file dated 2026-10-23. Publisher page
The FDA label says: “MIEBO ®(perfluorohexyloctane ophthalmic solution) is indicated for the treatment of the signs and symptoms of dry eye disease (DED).”
Run it in Rivvi
Which 2027 plans near you dropped or restricted Miebo?
Tier changes and new prior auth, step therapy or quantity limits, plan by plan.
Free to start. Opens Rivvi, the AI workspace for healthcare teams.
Miebo, solution
Indications and Usage, quoted from the label by Bausch & Lomb Incorporated (NDA216675). Cross-references to other label sections are left out.
MIEBO ®(perfluorohexyloctane ophthalmic solution) is indicated for the treatment of the signs and symptoms of dry eye disease (DED).
Source: DailyMed label, set id 6b283c02-7df4-4c00-951b-555cddffe77c, version 12, effective March 10, 2026. NDC 24208-377, one of 1 listing for this product.
Questions
What is Miebo used for?
The FDA label says: “MIEBO ®(perfluorohexyloctane ophthalmic solution) is indicated for the treatment of the signs and symptoms of dry eye disease (DED).”
What drug class is Miebo?
FDA lists perfluorohexyloctane in the Semifluorinated Alkane established pharmacologic class.
Does this page cover off-label uses or dosing?
No. This page shows only the Indications and Usage section of the FDA label. Ask a pharmacist or prescriber about dosing.